United States · FDA National Drug Code directory
Levocetirizine Dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-639_f380ef7e-eece-412d-b50c-deae2f6098d5
- Product NDC
- 10135-639
- Form
- TABLET, FILM COATED
- Composition / generic term
- levocetirizine Dihydrochloride
- Labeler
- Marlex Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180901
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (10135-639-30) · 10135-639-30
- 90 TABLET, FILM COATED in 1 BOTTLE (10135-639-90) · 10135-639-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →